HWM
KROS icon

HighMark Wealth Management’s Keros Therapeutics KROS Stock Holding History

HighMark Wealth Management’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-75
Closed -$3.43K – 610
2024
Q2 		$3.43K Hold
75
– – ﹤0.01% 420
2024
Q1 		$4.96K Hold
75
– – ﹤0.01% 375
2023
Q4 		$2.98K Hold
75
– – ﹤0.01% 429
2023
Q3 		$2.39K Hold
75
– – ﹤0.01% 435
2023
Q2 		$3.01K Buy
+75
New +$3.29K ﹤0.01% 415
2021
Q4 		– Sell
-148
Closed -$3K – 514
2021
Q3 		$3K Buy
+148
New +$5.27K ﹤0.01% 419

Other funds holding KROS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return